Future adequately powerful trials are necessary to elucidate the role of IDO1 associated with the post-stroke immune-inflammatory responses in the pathogenesis of PSD, especially depression during the acute phase of stroke, from different perspectives. Here, IDO1 is linked to depressive disorder.